DJ Novavax Inc. Stock Underperforms Friday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Novavax Inc. $(NVAX)$ shed 5.59% to $8.45 Friday, on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 2.15% to 20,948.36 and Dow Jones Industrial Average falling 1.73% to 45,166.64.
This was the stock's second consecutive day of losses.
Novavax Inc. closed 29.41% short of its 52-week high of $11.97, which the company achieved on February 26th.
The stock underperformed when compared to some of its competitors Friday, as Johnson & Johnson $(JNJ)$ rose 0.51% to $240.45, Pfizer Inc. $(PFE)$ fell 1.92% to $27.04, and Merck & Co. Inc. $(MRK)$ rose 0.59% to $119.63.
Trading volume (3.9 M) remained 1.4 million below its 50-day average volume of 5.3 M.
Data source: Dow Jones Market Data, FactSet. Data compiled March 27, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
March 27, 2026 17:29 ET (21:29 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments